Immunodetection of Cyclooxygenase-2 (COX-2) is Restricted to Tissue Macrophages in Normal Rat Liver and to Recruited Mononuclear Phagocytes in Liver Injury and Cholangiocarcinoma
Overview
Cell Biology
Authors
Affiliations
It has been suggested that cyclooxygenase-2 (COX-2)-mediated prostaglandin synthesis is associated with liver inflammation and carcinogenesis. The aim of this study is to identify the cellular source of COX-2 expression in different stages, from acute liver injury through liver fibrosis to cholangiocarcinoma (CC). We induced in rats acute and "chronic" liver injury (thioacetamide (TAA) or carbon tetrachloride (CCl(4))) and CC development (TAA) and assessed COX-2 gene expression in normal and damaged liver tissue by RT-PCR of total RNA. The cellular localization of COX-2 protein in liver tissue was analyzed by immunohistochemistry as well as in isolated rat liver cells by Western blotting. The findings were compared with those obtained in human cirrhotic liver tissue. The specificity of the antibodies was tested by 2-DE Western blot and mass spectrometric identification of the positive protein spots. RT-PCR analysis of total RNA revealed an increase of hepatic COX-2 gene expression in acutely as well as "chronically" damaged liver. COX-2-protein was detected in those ED1(+)/ED2(+) cells located in the non-damaged tissue (resident tissue macrophages). In addition COX-2 positivity in inflammatory mononuclear phagocytes (ED1(+)/ED2(-)), which were also present within the tumoral tissue was detected. COX-2 protein was clearly detectable in isolated Kupffer cells as well as (at lower level) in isolated "inflammatory" macrophages. Similar results were obtained in human cirrhotic liver. COX-2 protein is constitutively detectable in liver tissue macrophages. Inflammatory mononuclear phagocytes contribute to the increase of COX-2 gene expression in acute and chronic liver damage induced by different toxins and in the CC microenvironment.
Zhang L, Zhao C, Dai W, Tong H, Yang W, Huang Z Cell Mol Life Sci. 2023; 80(12):379.
PMID: 38010435 PMC: 11072584. DOI: 10.1007/s00018-023-05032-y.
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis.
Tu T, Alba M, Datta A, Hong H, Hua B, Jia Y Front Oncol. 2022; 12:958696.
PMID: 36276076 PMC: 9581256. DOI: 10.3389/fonc.2022.958696.
Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model.
Cheng X, Jia J, Zhang T, Zhang X, Vlodavsky I, Li J Cells. 2022; 11(13).
PMID: 35805119 PMC: 9265342. DOI: 10.3390/cells11132035.
Chang G, Lin W, Lin T, Liao H, Lu Y Int J Mol Sci. 2021; 22(21).
PMID: 34768813 PMC: 8583725. DOI: 10.3390/ijms222111383.
The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice.
Tsai M, Yang W, Lin C, Wang C, Liu H, Lin C Molecules. 2021; 26(7).
PMID: 33808318 PMC: 8036993. DOI: 10.3390/molecules26071937.